The Claim
In adults with type 2 diabetes, a low-carbohydrate diet is non-inferior to canagliflozin in reducing HbA1c over a 3-month period, with the 95% confidence interval for the difference in HbA1c change falling within the predefined non-inferiority margin of -0.85% to 0.08%.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with type 2 diabetes, a low-carbohydrate diet reduces HbA1c levels by an amount that is not worse than the reduction achieved by canagliflozin over three months, with the difference between the two treatments falling within a predefined acceptable range.
See the scientific wording
In adults with type 2 diabetes, a low-carbohydrate diet is non-inferior to canagliflozin for HbA1c reduction over 3 months, with a 95% confidence interval for the difference in HbA1c change ranging from -0.85% to 0.08%, meeting the predefined non-inferiority margin.
When a person eats fewer carbohydrates, the liver makes less sugar and the body uses insulin more effectively, which lowers blood sugar levels over time and reduces the amount of sugar stuck to hemoglobin in red blood cells.
What the research says
1 studyIn a study of people with type 2 diabetes, eating fewer carbs lowered blood sugar just as well as the drug canagliflozin — and in some ways even better. The results show the diet worked at least as well as the medicine over three months.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.